| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Precision Nanomedicine |
2025―Dec―16 |
Nanomaterials in the COVID-19 Era: A Promising Therapeutic Platform |
Mohammad Hosein Fathian Nasab, Mohammad Amin Manavi, Mohammad Hamrahi, Fatemeh Khonsari, Mohaddeseh Gelivarisarshari, Aryan Foroohari, et al. (+3) Mohammad Dehghani, Sheyda Ranjbar, Fatemeh Atyabi |
| 2 |
[GO] |
Precision Nanomedicine |
2022―Jul―26 |
Long COVID, Music, BBB, and Nanomedicines |
Kelly Cruz Contreras, Attila Pavláth, Horst-Dieter Försterling, Andrei Sommer |
| 3 |
[GO] |
Precision Nanomedicine |
2021―Jul―24 |
Personalized-dose Covid-19 vaccination in a wave of virus Variants of Concern: Trading individual efficacy for societal benefit |
Patrick Hunziker |
| 4 |
[GO] |
Precision Nanomedicine |
2021―Jun―27 |
ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2 |
Barbara Poddesu, Giulia Cugia, Franco Lori, Davide De Forni |
| 5 |
[GO] |
Precision Nanomedicine |
2021―Jun―21 |
Pulmonary and intranasal delivery of thymoquinone-loaded nanoparticles for Mucormycosis & Covid-19 |
Andrei Sommer, Kurt Naber, Horst-Dieter Försterling, Ramasamy Pitchappan |
| 6 |
[GO] |
Precision Nanomedicine |
2021―Mar―18 |
Rethinking Our COVID-19 Strategy |
Samuel Brauer |
| 7 |
[GO] |
Precision Nanomedicine |
2021―Jan―17 |
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro |
Guankui Wang, Hanmant Gaikwad, Mary McCarthy, Mercedes Gonzalez-Juarrero, Yue Li, Michael Armstrong, et al. (+3) Nichole Reisdorph, Thomas Morrison, Dmitri Simberg |
| 8 |
[GO] |
Precision Nanomedicine |
2021―Jan―17 |
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro |
Guankui Wang, Hanmant Gaikwad, Mary McCarthy, Mercedes Gonzalez-Juarrero, Yue Li, Michael Armstrong, et al. (+3) Nichole Reisdorph, Thomas Morrison, Dmitri Simberg |
| 9 |
[GO] |
Precision Nanomedicine |
2020―Jun―29 |
Elevated circulating endothelin-1 as a potential biomarker for high-risk COVID-19 severity |
Z Shadi Farhangrazi, S Moein Moghimi |
| 10 |
[GO] |
Precision Nanomedicine |
2020―May―20 |
Thymoquinone: shield and sword against SARS-CoV-2 |
Andrei P. Sommer, Horst-Dieter Försterling, Kurt G. Naber |
| 11 |
[GO] |
Precision Nanomedicine |
2020―Apr―28 |
Enhancing the Development of Therapeutics against SARS-CoV-2 by Exploring the Properties of Therapeutic Nano-structures |
Rodney Hill |
| 12 |
[GO] |
Precision Nanomedicine |
2020―Apr―10 |
Precision COVID-19 Vaccine with Companion Diagnostics |
Julianna Lisziewicz, Franco Lori |
